82 related articles for article (PubMed ID: 8539976)
1. Application of organic bound chrome in disturbed glycoregulation therapy.
Djordjević PB; Dimitrijević V; Maksimović R; Vrvić M; Vucetić J
Transplant Proc; 1995 Dec; 27(6):3333-4. PubMed ID: 8539976
[No Abstract] [Full Text] [Related]
2. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
Rave K; Heise T; Pfützner A; Boss AH
Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744
[No Abstract] [Full Text] [Related]
3. Therapy and clinical trials: glycaemia and prevention of macroangiopathy in type 2 diabetes.
Bolusani H; Peter R; Rees A
Curr Opin Lipidol; 2008 Dec; 19(6):629-30. PubMed ID: 18957889
[No Abstract] [Full Text] [Related]
4. [Treatment of hyperglycemia in adult-onset diabetes mellitus].
Yki-Järvinen H
Duodecim; 1999; 115(10):1155-64. PubMed ID: 11877855
[No Abstract] [Full Text] [Related]
5. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes.
Bahijiri SM; Mira SA; Mufti AM; Ajabnoor MA
Saudi Med J; 2000 Sep; 21(9):831-7. PubMed ID: 11376359
[TBL] [Abstract][Full Text] [Related]
6. [Clinical advances in diabetes].
Martin S; Scherbaum WA
Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1461-2. PubMed ID: 16794976
[No Abstract] [Full Text] [Related]
7. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
[TBL] [Abstract][Full Text] [Related]
9. Chromium in the prevention and control of diabetes.
Anderson RA
Diabetes Metab; 2000 Feb; 26(1):22-7. PubMed ID: 10705100
[TBL] [Abstract][Full Text] [Related]
10. Hemiballismus as a presenting sign of hyperglycemia.
Lietz TE; Huff JS
Am J Emerg Med; 1995 Nov; 13(6):647-8. PubMed ID: 7575804
[TBL] [Abstract][Full Text] [Related]
11. New paradigm for the mechanism and treatment of insulin resistance.
Lautt WW
Proc West Pharmacol Soc; 2002; 45():223-4. PubMed ID: 12434584
[No Abstract] [Full Text] [Related]
12. The therapeutic potential of glucose tolerance factor.
McCarty MF
Med Hypotheses; 1980 Nov; 6(11):1177-89. PubMed ID: 7005627
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
14. Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
Park SY; Choi YH; Lee W
J Ethnopharmacol; 2008 Feb; 115(3):473-82. PubMed ID: 18068920
[TBL] [Abstract][Full Text] [Related]
15. [Can natural substances prevent or improve type 2 diabetes mellitus? Coffee and cinnamon for control of hyperglycemia].
Stiefelhagen P
MMW Fortschr Med; 2005 Jun; 147(25):15. PubMed ID: 16038333
[No Abstract] [Full Text] [Related]
16. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
Stefan N; Stumvoll M; Bogardus C; Tataranni PA
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
[TBL] [Abstract][Full Text] [Related]
17. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
18. The clinical implications of insulin resistance.
Peters AL
Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
[TBL] [Abstract][Full Text] [Related]
19. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
20. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes: response to Martin et al.
Mark DA
Diabetes Care; 2006 Dec; 29(12):2764; author reply 2764-5. PubMed ID: 17130232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
